Sep 18, 2012
By:
Jennifer Markarian
Teva announced an agreement in which Bayer HealthCare will acquire the US-based animal health business of Teva Pharmaceutical Industries for up to $145 million. The transaction is expected to close in 2013, subject to antitrust clearance and other conditions.
|
Sep 11, 2012
By:
Jennifer Markarian
Pfizer and Mylan have agreed on terms by which Mylan may launch its generic version of Pfizer's Detrol LA (tolterodine tartrate) extended-release capsules, pending final approval by FDA.
|
Aug 28, 2012
By:
Jennifer Markarian
The Observational Medical Outcomes Partnership (OMOP), which is managed by the Foundation, desires feedback on proposed research priorities and tasks.
|
Aug 15, 2012
By:
Jennifer Markarian
Recycling is becoming a viable option for disposal of single-use systems.
|
Aug 14, 2012
By:
Jennifer Markarian
Zoetis, a subsidiary of Pfizer, filed a registration statement with the US Securities and Exchange Commission for a potential initial public offering of Class A common stock.
|
Jul 31, 2012
By:
Jennifer Markarian
Pharmaceutical industry leaders Pfizer, Novartis, Merck, and other companies released second-quarter 2012 results, emphasizing growth of new products and strength in emerging markets.
|
Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.
Jul 18, 2012
By:
Jennifer Markarian
Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.
|
Jul 16, 2012
By:
Jennifer Markarian
Global spending on medicines is estimated to reach nearly $1.2 trillion by 2016.
|
Jul 9, 2012
By:
Jennifer Markarian
ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.
|
|
